RPM TRADE RESTRAINTS LEGALIZED BY NEW SUPREME COURT RULING

Published Online: Wednesday, August 1, 2007

Community pharmacies may soon have less control over the prices they charge for OTC medications and other products, thanks to the US Supreme Court's recent ruling legalizing resale price maintenance (RPM) schemes.

These trade restraints' under which suppliers effectively dictate minimum retail prices for their products, have been treated as a federal antitrust law violation for much of the past century. In reversing course, the high court has given manufacturers of drugs, cosmetics, and other products a green light to establish resale prices for their items, and to refuse to sell to discount retailers who are unwilling to honor those minimum price levels.



Latest Articles
Patients with asthma can now access Spiriva Respimat with a prescription at pharmacies across the country.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Latest Issues
$auto_registration$
VSEO N/A